[HTML][HTML] Primary sclerosing cholangitis–a comprehensive review
TH Karlsen, T Folseraas, D Thorburn, M Vesterhus - Journal of hepatology, 2017 - Elsevier
Primary sclerosing cholangitis (PSC) is a rare disorder characterised by multi-focal bile duct
strictures and progressive liver disease. Inflammatory bowel disease is usually present and …
strictures and progressive liver disease. Inflammatory bowel disease is usually present and …
Primary sclerosing cholangitis
GM Hirschfield, TH Karlsen, KD Lindor, DH Adams - The Lancet, 2013 - thelancet.com
Primary sclerosing cholangitis is the classic hepatobiliary manifestation of inflammatory
bowel disease and is generally chronic and progressive. Patients frequently present with …
bowel disease and is generally chronic and progressive. Patients frequently present with …
Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis
Primary sclerosing cholangitis (PSC) is a severe liver disease of unknown etiology leading
to fibrotic destruction of the bile ducts and ultimately to the need for liver transplantation,,. We …
to fibrotic destruction of the bile ducts and ultimately to the need for liver transplantation,,. We …
Genetics of primary sclerosing cholangitis and pathophysiological implications
X Jiang, TH Karlsen - Nature reviews Gastroenterology & hepatology, 2017 - nature.com
Primary sclerosing cholangitis (PSC) is a chronic disease leading to fibrotic scarring of the
intrahepatic and extrahepatic bile ducts, causing considerable morbidity and mortality via …
intrahepatic and extrahepatic bile ducts, causing considerable morbidity and mortality via …
[PDF][PDF] Increased T helper type 17 response to pathogen stimulation in patients with primary sclerosing cholangitis
J Katt, D Schwinge, T Schoknecht, A Quaas… - …, 2013 - Wiley Online Library
T helper (Th) 17 cells are important for host defense against bacteria and fungi, but are also
involved in the pathogenesis of autoimmune diseases. In primary sclerosing cholangitis …
involved in the pathogenesis of autoimmune diseases. In primary sclerosing cholangitis …
Primary biliary cholangitis and primary sclerosing cholangitis: current knowledge of pathogenesis and therapeutics
JW Park, JH Kim, SE Kim, JH Jung, MK Jang, SH Park… - Biomedicines, 2022 - mdpi.com
Cholangiopathies encompass various biliary diseases affecting the biliary epithelium,
resulting in cholestasis, inflammation, fibrosis, and ultimately liver cirrhosis. Primary biliary …
resulting in cholestasis, inflammation, fibrosis, and ultimately liver cirrhosis. Primary biliary …
Reduced FOXP3+ regulatory T cells in patients with primary sclerosing cholangitis are associated with IL2RA gene polymorphisms
M Sebode, M Peiseler, B Franke, D Schwinge… - Journal of …, 2014 - Elsevier
Background & Aims Recently, genome wide association studies in primary sclerosing
cholangitis (PSC) revealed associations with gene polymorphisms that potentially could …
cholangitis (PSC) revealed associations with gene polymorphisms that potentially could …
Pharmacogenomics of drug-induced liver injury (DILI): molecular biology to clinical applications
K Kaliyaperumal, JI Grove, RM Delahay… - Journal of …, 2018 - Elsevier
Clinical vignette A 21-year old woman was admitted to hospital with a two-week history of
painless jaundice, fatigue and anorexia having previously been fit and well. One month prior …
painless jaundice, fatigue and anorexia having previously been fit and well. One month prior …
Immunomodulatory effect of vancomycin on Treg in pediatric inflammatory bowel disease and primary sclerosing cholangitis
DN Abarbanel, SM Seki, Y Davies, N Marlen… - Journal of clinical …, 2013 - Springer
Vancomycin has been shown to affect tumor necrosis factor-alpha (TNF-α) pathways as an
immunomodulator; this is thought to be separate from its function as an antibiotic [1] …
immunomodulator; this is thought to be separate from its function as an antibiotic [1] …
[PDF][PDF] Akt‐mediated foxo1 inhibition is required for liver regeneration
M Pauta, N Rotllan, A Fernández‐Hernando… - …, 2016 - Wiley Online Library
Understanding the hepatic regenerative process has clinical interest as the effectiveness of
many treatments for chronic liver diseases is conditioned by efficient liver regeneration …
many treatments for chronic liver diseases is conditioned by efficient liver regeneration …